Antibody array-based proteomic screening of novel biomarkers in malignant biliary stricture

WH Qin, JT Liu, SP Wang, ZS Yang… - Cancer …, 2022 - content.iospress.com
BACKGROUND: Distinguishing between benign and malignant bile duct strictures has long
been a diagnostic challenge in clinical practice. OBJECTIVE: This study aimed to discover …
相关文章

Antibody array-based proteomic screening of novel biomarkers in malignant biliary stricture

WH Qina, JT Liua, SP Wanga, ZS Yangb… - Cancer …, 2022 - content.iospress.com
BACKGROUND: Distinguishing between benign and malignant bile duct strictures has long
been a diagnostic challenge in clinical practice. OBJECTIVE: This study aimed to discover …

Antibody array-based proteomic screening of novel biomarkers in malignant biliary stricture.

WH Qin, JT Liu, SP Wang, ZS Yang… - … Biomarkers: Section A …, 2022 - europepmc.org
Background Distinguishing between benign and malignant bile duct strictures has long
been a diagnostic challenge in clinical practice. Objective This study aimed to discover …

Antibody array-based proteomic screening of novel biomarkers in malignant biliary stricture

WH Qin, JT Liu, SP Wang, ZS Yang… - … : section A of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Distinguishing between benign and malignant bile duct strictures has long
been a diagnostic challenge in clinical practice. Objective This study aimed to discover …